"Designing Growth Strategies is in our DNA"

Human Papillomavirus (HPV) Vaccine Market Size, Share & COVID-19 Impact Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2020-2027

Last Updated: March 03, 2025 | Format: PDF | Report ID: FBI101962

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Pipeline Analysis
    2. Technological Advancements in the Human Papillomavirus Vaccine Market
    3. Regulatory Scenario -  For Key Countries, 2019
    4. Prevalence of Cervical Cancer -  For Key Countries, 2019
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Human Papillomavirus Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Bivalent
      2. Polyvalent
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. HPV Associated Cancer
      2. Genital Warts
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & Services, SWOT analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. GlaxoSmithKline plc.
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Merck & Co., Inc
        1. Overview,
        2. Products & Services,
        3. SWOT analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Human Papillomavirus Vaccine Market Revenue Breakdown (USD Bn, %) by Region, 2019 & 2027

Figure 2:  Global Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019 & 2027

Figure 3:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Bivalent, 2016-2027

Figure 4:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Polyvalent, 2016-2027

Figure 5:  Global Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019 & 2027

Figure 6:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by HPV Associated Cancer, 2016-2027

Figure 7:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Genital Warts, 2016-2027

Figure 8:  Global Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 9:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Hospital & Retail Pharmacies, 2016-2027

Figure 10:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Government Suppliers, 2016-2027

Figure 11:  Global Human Papillomavirus Vaccine Market Forecast (USD Bn), by Others, 2016-2027

Figure 12:  Global Human Papillomavirus Vaccine Market Value (USD Bn), by Region, 2019 & 2027

Figure 13:  North America Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 14:  North America Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 15:  North America Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 16:  North America Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 17:  North America Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 18:  North America Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 19:  North America Human Papillomavirus Vaccine Market Value (USD Bn), By Country, 2019 & 2027

Figure 20:  North America Human Papillomavirus Vaccine Market Value Share (%), By Country, 2019

Figure 21:  Europe Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 22:  Europe Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 23:  Europe Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 24:  Europe Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 25:  Europe Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 26:  Europe Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 27:  Europe Human Papillomavirus Vaccine Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 28:  Europe Human Papillomavirus Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 29:  Asia Pacific Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 30:  Asia Pacific Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 31:  Asia Pacific Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 32:  Asia Pacific Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 33:  Asia Pacific Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 34:  Asia Pacific Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 35:  Asia Pacific Human Papillomavirus Vaccine Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 36:  Asia Pacific Human Papillomavirus Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 37:  Latin America Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 38:  Latin America Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 39:  Latin America Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 40:  Latin America Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 41:  Latin America Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 42:  Latin America Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 43:  Latin America Human Papillomavirus Vaccine Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 44:  Latin America Human Papillomavirus Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 45:  Middle East & Africa Human Papillomavirus Vaccine Market Value (USD Bn), by Type, 2019 & 2027

Figure 46:  Middle East & Africa Human Papillomavirus Vaccine Market Value Share (%), by Type, 2019

Figure 47:  Middle East & Africa Human Papillomavirus Vaccine Market Value (USD Bn), by Disease Indication, 2019 & 2027

Figure 48:  Middle East & Africa Human Papillomavirus Vaccine Market Value Share (%), by Disease Indication, 2019

Figure 49:  Middle East & Africa Human Papillomavirus Vaccine Market Value (USD Bn), by Distribution Channel, 2019 & 2027

Figure 50:  Middle East & Africa Human Papillomavirus Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 51:  Middle East & Africa Human Papillomavirus Vaccine Market Value (USD Bn), By Country/ Sub-region, 2019 & 2027

Figure 52:  Middle East & Africa Human Papillomavirus Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 53:  Global Human Papillomavirus Vaccine Market Share (%), By Company, 2019

Table 1:  Global Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016–2027

Table 2:  Global Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016–2027

Table 3:  Global Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016–2027

Table 4:  Global Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Region, 2016-2027

Table 5:  North America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 6:  North America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 7:  North America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 8:  North America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country, 2016-2027

Table 9:  Europe Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 10:  Europe Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 11:  Europe Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 12:  Europe Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 13:  Asia Pacific Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 14:  Asia Pacific Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 15:  Asia Pacific Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 16:  Asia Pacific Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 17:  Latin America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 18:  Latin America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 19:  Latin America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Latin America Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Middle East & Africa Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Type, 2016-2027

Table 22:  Middle East & Africa Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Disease Indication, 2016-2027

Table 23:  Middle East & Africa Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, by Distribution Channel, 2016-2027

Table 24:  Middle East & Africa Human Papillomavirus Vaccine Market Revenue (USD Bn) Forecast, By Country/ Sub-region, 2016-2027

Human Papillomavirus (HPV) Vaccines Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?